Hypurin Porcine Neutral 100units/ml solution for injection 10ml vials

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Insulin soluble porcine

Available from:

Wockhardt UK Ltd

ATC code:

A10AB03

INN (International Name):

Insulin soluble porcine

Dosage:

100unit/1ml

Pharmaceutical form:

Solution for injection

Administration route:

Subcutaneous; Intramuscular; Intravenous

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 06010101; GTIN: 5012727901930

Patient Information leaflet

MEASURE BAR SHOULD BE 150MM AT 100% SCALE
Customer
Description
Item Code
Profile
Size
Min. Point Size
Market
Language
Proof By
Proof No.
Date
Artwork No.
Pharma
Code
Colours Used
Wockhardt UK Limited
LFT HYPUR P 100U-ML VIA COMMON
104498/5
As per uploaded pdf
148 x 350mm
matt.pirie-scott
2
29/10/2015
607804
120
Process Black
Keylines
[e-mail]
CLEARLY MARK ANY AMENDMENTS ON ONE PROOF AND RETURN TO MPS
WARNING! We cannot accept responsibility for any errors
in this proof after approval. Whilst we take extreme care
at all times to ensure accuracy to our clientʼs brief,
the final responsibility must be taken by our client.
IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING
FULL APPROVAL OF DESIGN AND TEXT.
UK
English
8pt (main body) / 8pt (variables)
PACKAGE LEAFLET: INFORMATION FOR THE USER
HYPURIN
® PORCINE RANGE OF INSULIN
INJECTION
READ ALL OF THIS LEAFLET CAREFULLY
BEFORE YOU INJECT YOUR INSULIN.
- Keep this leaflet. You may need
to read it again while you are
receiving your treatment.
- If you have any further questions,
please
ask
your
doctor,
pharmacist or diabetes nurse.
- This
medicine
has
been
prescribed for you. It must not be
shared with other patients. It may
harm them even if their symptoms
are the same as yours.
IN THIS LEAFLET:
1. What Hypurin
®
is and what it is used for
2. Before you receive Hypurin
®
3. How to use Hypurin
®
4. Possible side effects
5. How to store Hypurin
®
6. Further information
1. WHAT HYPURIN
® IS AND WHAT IT IS USED FOR
The name of your medicine is Hypurin Porcine Insulin.
Hypurin Porcine is the brand name for a range of highly
purified porcine (pig) insulin injections.
Hypurin Porcine Neutral is a sterile, clear solution of porcine
insulin (100 international units/ml). It is short acting.
Hypurin Porcine Isophane is a sterile, white suspension of
porcine insulin (100 international units/ml) with protamine
sulphate and zinc chloride in water. It is longer acting than
Hypurin Porcine Neutral.
Hypurin Porcine 30/70 Mix is a sterile, white suspension
of porcin

Summary of Product characteristics

OBJECT 1
HYPURIN PORCINE NEUTRAL VIALS - PL 29831/0126
Summary of Product Characteristics Updated 19-Jan-2016 | Wockhardt UK
Ltd
1. Name of the medicinal product
Hypurin® Porcine Neutral
2. Qualitative and quantitative composition
Crystalline Insulin Ph Eur (Porcine) 100IU/ml.
Neutral Insulin Injection Ph Eur (Porcine)
For excipients, see 6.1
3. Pharmaceutical form
Solution for injection
A clear, colourless solution
4. Clinical particulars
4.1 Therapeutic indications
The treatment of insulin dependent diabetes mellitus.
May be used for diabetics who require an insulin of prompt onset and
short duration. It is a suitable
preparation for admixture with longer acting insulins. It is
particularly useful where intermittent, short
term or emergency therapy is required, during initial stabilisation
and in the treatment of labile diabetes.
4.2 Posology and method of administration
To be determined by the physician according to the needs of the
patient.
Usually administered subcutaneously but where necessary it may be
given intramuscularly or
intravenously. After subcutaneous injection onset of action occurs
within 30-60 minutes with an overall
duration of 6-8 hours. Maximum effect is exerted over the mid-range.
4.3 Contraindications
Hypoglycaemia.
Hypersensitivity to insulin or to any of the excipients.
4.4 Special warnings and precautions for use
Hypoglycaemia: Susceptibility to hypoglycaemia may be increased by an
inaccurate or excessive dosage
of insulin, the omission of a meal by the patient or increased
physical activity. Correct insulin
administration and awareness of the symptoms of hypoglycaemia are
essential to reduce the risk of
hypoglycaemia (see section 4.9).
Blood or urinary glucose concentrations should be monitored and the
urine tested for ketones by patients
on insulin therapy.
Newly diagnosed diabetic patients may experience fluctuating insulin
requirements during the first weeks,
months or even years of treatment (the so-called 'honeymoon period').
Patients transferred to Hypurin® Porcine insulins fro